Using the same melanoma cell lines, Zhao et al showed that Dectin-1-activated dendritic cells also promote the differentiation of naive CD4 + T cells to Th9, inducing antitumor responses and controlling disease (Zhao et al, 2016). Here, CLEC7A is linked to melanoma.